https://tiefenbachergroup.com/2023/05/10/successful-approval-of-manufacturing-and-laboratory-facilities-by-saudi-food-and-drug-authority/
https://tiefenbachergroup.com/2023/03/14/new-market-launch-tiefenbacher-pharmaceuticals-successfully-launches-the-antihistamine-bilastine-for-a-market-entry-as-over-the-counter-otc-medicine-in-germany/
https://tiefenbachergroup.com/2023/02/25/tiefenbacher-groups-manufacturing-sites-have-been-successfully-registered-by-the-united-arab-emirates-ministry-of-health/
https://tiefenbachergroup.com/2022/12/01/new-market-launch-tiefenbacher-pharmaceuticals-successfully-launches-generic-version-of-the-psoriasis-medication-apremilast-in-canada/
https://tiefenbachergroup.com/2022/11/10/thanks-for-visiting-us-at-cphi-2022-in-frankfurt/
https://tiefenbachergroup.com/2022/10/28/tiefenbacher-group-opens-new-manufacturing-site-in-cyprus/
https://tiefenbachergroup.com/2022/10/25/tiefenbacher-group-and-ondosis-launch-the-innovative-healthcare-brand-oysta/
https://tiefenbachergroup.com/2022/10/20/new-market-launch-tiefenbacher-pharmaceuticals-successfully-launches-generic-version-of-the-anticoagulant-medicine-apixaban-in-canada/
https://tiefenbachergroup.com/2022/10/04/meet-tiefenbacher-group-at-cphi-in-frankfurt-from-1-3-nov-and-discover-our-latest-ideas-to-make-pharmaceuticals-more-affordable-more-available-and-better-than-before/